JP2024045291A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024045291A5 JP2024045291A5 JP2024008397A JP2024008397A JP2024045291A5 JP 2024045291 A5 JP2024045291 A5 JP 2024045291A5 JP 2024008397 A JP2024008397 A JP 2024008397A JP 2024008397 A JP2024008397 A JP 2024008397A JP 2024045291 A5 JP2024045291 A5 JP 2024045291A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- thiazole
- carboxamide
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762541403P | 2017-08-04 | 2017-08-04 | |
| US62/541,403 | 2017-08-04 | ||
| PCT/US2018/045183 WO2019028362A1 (en) | 2017-08-04 | 2018-08-03 | INHIBITORS OF PLASMATIC KALLIKREIN AND USES THEREOF |
| JP2020505842A JP7210540B2 (ja) | 2017-08-04 | 2018-08-03 | 血漿カリクレインの阻害剤およびその使用 |
| JP2023002547A JP7427812B2 (ja) | 2017-08-04 | 2023-01-11 | 血漿カリクレインの阻害剤およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023002547A Division JP7427812B2 (ja) | 2017-08-04 | 2023-01-11 | 血漿カリクレインの阻害剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024045291A JP2024045291A (ja) | 2024-04-02 |
| JP2024045291A5 true JP2024045291A5 (enExample) | 2024-04-24 |
| JP7785108B2 JP7785108B2 (ja) | 2025-12-12 |
Family
ID=63209746
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505842A Active JP7210540B2 (ja) | 2017-08-04 | 2018-08-03 | 血漿カリクレインの阻害剤およびその使用 |
| JP2023002547A Active JP7427812B2 (ja) | 2017-08-04 | 2023-01-11 | 血漿カリクレインの阻害剤およびその使用 |
| JP2024008397A Active JP7785108B2 (ja) | 2017-08-04 | 2024-01-24 | 血漿カリクレインの阻害剤およびその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505842A Active JP7210540B2 (ja) | 2017-08-04 | 2018-08-03 | 血漿カリクレインの阻害剤およびその使用 |
| JP2023002547A Active JP7427812B2 (ja) | 2017-08-04 | 2023-01-11 | 血漿カリクレインの阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11168083B2 (enExample) |
| EP (2) | EP4494698A3 (enExample) |
| JP (3) | JP7210540B2 (enExample) |
| AU (3) | AU2018311976B2 (enExample) |
| CA (1) | CA3070717A1 (enExample) |
| WO (1) | WO2019028362A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7210540B2 (ja) | 2017-08-04 | 2023-01-23 | 武田薬品工業株式会社 | 血漿カリクレインの阻害剤およびその使用 |
| KR20200143376A (ko) * | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| US11787796B2 (en) * | 2019-09-18 | 2023-10-17 | Takeda Pharmaceutical Company Limited | Plasma Kallikrein inhibitors and uses thereof |
| CN114667289B (zh) | 2019-09-18 | 2025-08-26 | 武田药品工业有限公司 | 杂芳基血浆激肽释放酶抑制剂 |
| US20230192889A1 (en) * | 2020-01-13 | 2023-06-22 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack |
| WO2021198534A1 (en) | 2020-04-04 | 2021-10-07 | Oxurion NV | Plasma kallikrein inhibitors for use in the treatment of coronaviral disease |
| WO2023144030A1 (en) | 2022-01-31 | 2023-08-03 | Oxurion NV | Plasma kallikrein inhibitor therapy for anti-vegf sensitization |
| WO2023148016A1 (en) | 2022-02-04 | 2023-08-10 | Oxurion NV | Biomarker for plasma kallikrein inhibitor therapy response |
| WO2024059186A1 (en) * | 2022-09-15 | 2024-03-21 | Takeda Pharmaceutical Company Limited | N-((isoquinolin-6-yl)methyl)-1h-pyrazole-4-carboxamid derivatives as plasma kallikrein inhibitors for the treatment of hereditary angioedema |
| CN116063215A (zh) * | 2023-02-23 | 2023-05-05 | 南京安淮创新药物研究院有限公司 | 一种4-氨基-l-脯氨酸的合成方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID27414A (id) | 1998-06-30 | 2001-04-05 | Pfizer Produsts Inc | Penghambat-penghambat non-peptidil dari pengikat sel tergantung vla-4 yang bermanfaat dalam pengobatan penyakit-penyakit inflamasi, autoimun dan pernafasan |
| CN101336229B (zh) * | 2005-12-23 | 2012-06-13 | 西兰岛药物有限公司 | 改性的拟赖氨酸化合物 |
| US20120009141A1 (en) * | 2008-08-07 | 2012-01-12 | Pharmascience Inc. | Functionalized pyrrolidines and use thereof as iap inhibitors |
| US9079880B2 (en) * | 2010-07-07 | 2015-07-14 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
| WO2013111108A1 (en) | 2012-01-27 | 2013-08-01 | Novartis Ag | 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| KR20140130449A (ko) * | 2012-02-24 | 2014-11-10 | 에프. 호프만-라 로슈 아게 | 항바이러스 화합물 |
| GB201209138D0 (en) * | 2012-05-24 | 2012-07-04 | Ono Pharmaceutical Co | Compounds |
| JP6337750B2 (ja) * | 2013-11-22 | 2018-06-06 | 小野薬品工業株式会社 | 化合物 |
| CA2977993A1 (en) * | 2015-02-27 | 2016-09-01 | Verseon Corporation | Substituted pyrazole compounds as serine protease inhibitors |
| IL254292B1 (en) * | 2015-03-30 | 2025-09-01 | Dyax Corp | Plasma kallikrein inhibitors and their uses for preventing the onset of hereditary angioedema |
| EP3317241A4 (en) * | 2015-07-01 | 2019-01-23 | Lifesci Pharmaceuticals, Inc. | THERAPEUTIC INHIBITING COMPOUNDS |
| HUE057106T2 (hu) * | 2015-10-01 | 2022-04-28 | Biocryst Pharm Inc | Humán plazma kallikrein gátlók |
| JP7210540B2 (ja) | 2017-08-04 | 2023-01-23 | 武田薬品工業株式会社 | 血漿カリクレインの阻害剤およびその使用 |
| KR20200143376A (ko) * | 2018-03-13 | 2020-12-23 | 샤이어 휴먼 지네틱 테라피즈 인크. | 혈장 칼리크레인 억제제로서의 치환된 이미다조피리딘 및 이의 용도 |
| CN114667289B (zh) * | 2019-09-18 | 2025-08-26 | 武田药品工业有限公司 | 杂芳基血浆激肽释放酶抑制剂 |
| US11787796B2 (en) * | 2019-09-18 | 2023-10-17 | Takeda Pharmaceutical Company Limited | Plasma Kallikrein inhibitors and uses thereof |
| JP2023522331A (ja) * | 2020-04-17 | 2023-05-30 | 武田薬品工業株式会社 | 血漿カリクレインの阻害剤の形態及び組成物 |
-
2018
- 2018-08-03 JP JP2020505842A patent/JP7210540B2/ja active Active
- 2018-08-03 EP EP24203482.5A patent/EP4494698A3/en active Pending
- 2018-08-03 US US16/636,518 patent/US11168083B2/en active Active
- 2018-08-03 WO PCT/US2018/045183 patent/WO2019028362A1/en not_active Ceased
- 2018-08-03 AU AU2018311976A patent/AU2018311976B2/en active Active
- 2018-08-03 CA CA3070717A patent/CA3070717A1/en active Pending
- 2018-08-03 EP EP18755681.6A patent/EP3661922B1/en active Active
-
2021
- 2021-11-04 US US17/519,013 patent/US11905285B2/en active Active
-
2023
- 2023-01-11 JP JP2023002547A patent/JP7427812B2/ja active Active
- 2023-01-12 AU AU2023200156A patent/AU2023200156B2/en active Active
- 2023-12-20 US US18/390,137 patent/US20240199602A1/en active Pending
-
2024
- 2024-01-24 JP JP2024008397A patent/JP7785108B2/ja active Active
-
2025
- 2025-06-26 AU AU2025204840A patent/AU2025204840A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024045291A5 (enExample) | ||
| JP2023040213A5 (enExample) | ||
| DE60316440T2 (de) | Benzo-kondensierte heteroarylamid-derivative von thienopyridinen nützlich als therapeutische agentien, entsprechende pharmazeutische zusammensetzungen, und methoden für ihre verwendung | |
| JP2020529998A5 (enExample) | ||
| CA2869337C (en) | Cyclic amides as metap-2 inhibitors | |
| TWI501963B (zh) | 特定胺基－嗒類，與其組成物，及其使用方法 | |
| AU2001294117B2 (en) | Combination use of acetylcholinesterase inhibitors and GABAA inverse agonists for the treatment of cognitive disorders | |
| TWI298066B (en) | Diamine derivatives | |
| JP5852099B2 (ja) | ある種のアミノ−ピリミジン、その組成物、及びそれを用いるための方法 | |
| DK2589592T3 (en) | Hitherto UNKNOWN NICOTINAMIDE DERIVATIVES OR SALTS THEREOF | |
| JP6440625B2 (ja) | 精神分裂病を処置するための方法および組成物 | |
| KR20180043343A (ko) | 의학적 질병의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 화합물 | |
| JP2020531498A5 (enExample) | ||
| JP2009529047A5 (enExample) | ||
| EP2099453A2 (de) | Kombinationstherapie substituierter oxazolidinone | |
| SG183263A1 (en) | Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction | |
| KR20170031669A (ko) | 치환된 우레아 유도체 및 이의 약제학적 용도 | |
| CN101678107A (zh) | 用于治疗杜兴型肌营养不良的药物组合物 | |
| RU2006126663A (ru) | Полициклические средства для лечения респираторно-синцитиальных вирусных инфекций | |
| JP2003516987A5 (enExample) | ||
| WO2007039134A1 (de) | Kombinationstherapie mit substituierten oxazolidinonen zur prophylaxe und behandlung von cerebralen durchblutungsstörungen | |
| US20170015654A1 (en) | Pyridazine compound | |
| IL272952B2 (en) | Modified derivatives of 2-aza-bicyclo[3.1.1]-heptane and 2-aza-bicyclo[3.2.1]-octane as orexin receptor blockers | |
| MXPA00013030A (es) | Sulfonamidas n-enlazadas de acidos carboxilicos n-heterociclicos o isoesteres, para las enfermedades de la vision y la memoria. | |
| JP7356352B2 (ja) | 眼疾患の予防方法又は処置方法 |